Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 17.31x is in line with its 5-year average of 17.99x, near the high end of its 5-year range (-18.09x–25.12x).
20.71% above its 12-month average of 14.34x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -1.30x.
INTEREST COVERAGE RATIO
17.31x
INTEREST COVERAGE RATIO AVG TTM
14.34x
INTEREST COVERAGE RATIO AVG 3Y
14.17x
INTEREST COVERAGE RATIO AVG 5Y
17.99x
INTEREST COVERAGE RATIO AVG 10Y
15.51x
INTEREST COVERAGE RATIO AVG 15Y
13.70x
INTEREST COVERAGE RATIO AVG 20Y
13.69x
CURRENT VS TTM AVG
+20.71%
CURRENT VS 3Y AVG
+22.14%
CURRENT VS 5Y AVG
-3.78%
CURRENT VS 10Y AVG
+11.57%
CURRENT VS 15Y AVG
+26.32%
CURRENT VS 20Y AVG
+26.42%
SECTOR MEDIAN · HEALTHCARE
6.88x
median of 82 covered companies
CURRENT VS SECTOR MEDIAN
+151.42%
vs the sector median at left
Merck & Co., Inc.
Market Cap
$354.05B
Interest Coverage Ratio
17.31x
TTM Avg
14.34x
3Y Avg
14.17x
5Y Avg
17.99x
Market Cap
$349.33B
Interest Coverage Ratio
14.34x
TTM Avg
11.95x
3Y Avg
16.17x
5Y Avg
26.28x
Market Cap
$343.14B
Interest Coverage Ratio
4.74x
TTM Avg
6.50x
3Y Avg
9.14x
5Y Avg
10.75x
Market Cap
$252.76B
Interest Coverage Ratio
8.11x
TTM Avg
7.03x
3Y Avg
5.51x
5Y Avg
4.49x
Market Cap
$461.59B
Interest Coverage Ratio
6.94x
TTM Avg
5.10x
3Y Avg
6.01x
5Y Avg
6.01x
Market Cap
$233.32B
Interest Coverage Ratio
5.71x
TTM Avg
5.17x
3Y Avg
6.77x
5Y Avg
10.10x
Market Cap
$203.64B
Interest Coverage Ratio
3.88x
TTM Avg
3.09x
3Y Avg
3.93x
5Y Avg
4.89x
Market Cap
$189.15B
Interest Coverage Ratio
30.34x
TTM Avg
54.30x
3Y Avg
123.94x
5Y Avg
139.58x
Market Cap
$179.79B
Interest Coverage Ratio
11.43x
TTM Avg
6.56x
3Y Avg
7.26x
5Y Avg
7.18x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Merck & Co., Inc. (MRK) | $354.05B | 17.31x | 14.34x | 14.17x | 17.99x |
| Roche Holding AG (RHHBY)vs › | $349.33B | 14.34x | 11.95x | 16.17x | 26.28x |
| UnitedHealth Group Incorporated (UNH)vs › | $343.14B | 4.74x | 6.50x | 9.14x | 10.75x |
| AstraZeneca PLC (AZN)vs › | $252.76B | 8.11x | 7.03x | 5.51x | 4.49x |
| AbbVie Inc. (ABBV)vs › | $461.59B | 6.94x | 5.10x | 6.01x | 6.01x |
| Thermo Fisher Scientific Inc. (TMO)vs › | $233.32B | 5.71x | 5.17x | 6.77x | 10.10x |
| Amgen Inc. (AMGN)vs › | $203.64B | 3.88x | 3.09x | 3.93x | 4.89x |
| Novo Nordisk A/S (NVO)vs › | $189.15B | 30.34x | 54.30x | 123.94x | 139.58x |
| Gilead Sciences, Inc. (GILD)vs › | $179.79B | 11.43x | 6.56x | 7.26x | 7.18x |
| Abbott Laboratories (ABT)vs › | $176.24B | 23.60x | 17.46x | 17.67x | 16.77x |
Interest Coverage
17.3x
Debt/Equity
1.29
Current Ratio
1.32
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -1.30x |
| 2025-12-31 | 14.99x |
| 2025-09-30 | 22.82x |
| 2025-06-30 | 20.85x |
| 2025-03-31 | 21.44x |
| 2024-12-31 | 13.26x |
| 2024-09-30 | 12.07x |
| 2024-06-30 | 19.77x |
| 2024-03-31 | 19.01x |
| 2023-12-31 | -5.53x |
| 2023-09-30 | 18.52x |
| 2023-06-30 | -18.09x |
| 2023-03-31 | 15.73x |
| 2022-12-31 | 14.84x |
| 2022-09-30 | 16.83x |
| 2022-06-30 | 21.11x |
| 2022-03-31 | 23.14x |
| 2021-12-31 | 17.94x |
| 2021-09-30 | 25.12x |
| 2021-06-30 | 8.40x |
| 2021-03-31 | 14.14x |
| 2020-12-31 | -9.37x |
| 2020-09-30 | 12.35x |
| 2020-06-30 | 11.66x |
| 2020-03-31 | 18.78x |
| 2019-12-31 | 12.61x |
| 2019-09-30 | 11.32x |
| 2019-06-30 | 14.84x |
| 2019-03-31 | 16.31x |
| 2018-12-31 | 14.05x |
| 2018-09-30 | 14.02x |
| 2018-06-30 | 11.68x |
| 2018-03-31 | 6.21x |
| 2017-12-31 | 11.41x |
| 2017-09-30 | 0.77x |
| 2017-06-30 | 13.12x |
| 2017-03-31 | 11.45x |
| 2016-12-31 | -2.55x |
| 2016-09-30 | 18.06x |
| 2016-06-30 | 9.69x |
| 2016-03-31 | 10.25x |
| 2015-12-31 | 11.55x |
| 2015-09-30 | 14.18x |
| 2015-06-30 | 9.98x |
| 2015-03-31 | 9.26x |
| 2014-12-31 | 9.24x |
| 2014-09-30 | 8.90x |
| 2014-06-30 | 7.47x |
| 2014-03-31 | 10.92x |
| 2013-12-31 | 9.43x |
| 2013-09-30 | 11.47x |
| 2013-06-30 | 7.39x |
| 2013-03-31 | 9.88x |
| 2012-12-31 | 10.33x |
| 2012-09-30 | 13.31x |
| 2012-06-30 | 16.19x |
| 2012-03-31 | 15.76x |
| 2011-12-31 | 10.39x |
| 2011-09-30 | 13.50x |
| 2011-06-30 | 14.48x |
| 2011-03-31 | 11.82x |
| 2010-12-31 | -2.50x |
| 2010-09-30 | 8.21x |
| 2010-06-30 | 7.80x |
| 2010-03-31 | 5.15x |
| 2009-12-31 | -1.40x |
| 2009-09-30 | 12.55x |
| 2009-06-30 | 14.28x |
| 2009-03-31 | 19.68x |
| 2008-09-30 | 21.91x |
| 2008-06-30 | 30.75x |
| 2008-03-31 | 22.75x |